by American Heart Association edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes Credit: RDNE Stock project from Pexels Taking one pill that combines two or more blood pressure medications may help adults with high blood pressure (also known as hypertension) lower their blood pressure level faster and more effectively than taking multiple medications separately, and it […]
by Carole Tanzer Miller edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes Injure a tendon and you might not notice right away, but beware: These injuries often fail to heal properly, putting everyday activities at risk. “No matter how strong your muscle is, you’re not going to be able to have the functionality and the
How to head off tendon trouble Read More »
by Rong-Gong Lin II edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes Credit: Andrea Piacquadio from Pexels The dreaded norovirus—the “vomiting bug” that often causes stomach flu symptoms—is climbing again in California, and doctors warn that a new subvariant could make even more people sick this season. In L.A. County, concentrations of norovirus are already on the
The FDA has approved zoliflodacin, to be marketed as Nuzolvence, giving clinicians the first new, uniquely targeted treatment for gonorrhea in decades. The drug, made by Entasis Therapeutics, is now the second newly licensed option in as many days, after GSK’s gepotidacin — or Blujepa — received a supplemental approval, STAT’s Helen Branswell writes. The
Two oral drugs finally offer new ways to treat gonorrhea Read More »
Bhanvi Satija And Robin Respaut December 09, 2025 LONDON, Dec 9 (Reuters) – Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo Nordisk to manage the hormonal disorder’s symptoms, according to an exclusive analysis of U.S. patient records and interviews with obesity specialists and gynecologists. U.S. prescriptions
Weight-loss Drugs Fill a Treatment Gap for Women With Hormone Disorder PCOS, Doctors Say Read More »
Researchers will now work with industry to progress the discovery toward drug development for future testing Peer-Reviewed Publication University of Sydney World-first research published today by University of Sydney scientists has uncovered a mechanism that may explain why glioblastoma returns after treatment, offering new clues for future therapies which they will now investigate as part
Peer-Reviewed Publication Washington State University image: The WSU research team modulated one interaction of a common and complex virus protein, called glycoprotein B , to prevent viruses from fusing with cells and causing illness. view more Credit: WSU PULLMAN, Wash — Washington State University researchers have found a way to modulate a common virus protein to prevent
Modulating key interaction prevents virus from entering cells Read More »
by Zach Winn, Massachusetts Institute of Technology edited by Gaby Clark, reviewed by Robert Egan Editors’ notes Kano Therapeutics makes circular single stranded DNA (cssDNA) of custom lengths and sequences to improve genetic medicines. Pictured are Kano’s vials containing custom genetic constructs for an in vivo CAR-T study. Credit: Courtesy of Kano Therapeutics To our immune system, a
Circular single-stranded DNA molecules for safer genetic medicine Read More »
by Dalin Clark, Michigan State University edited by Andrew Zinin Editors’ notes Credit: Michigan State University Though an estimated 60 million people around the world have atrial fibrillation, or A-fib, a type of irregular and often fast heartbeat, it’s been at least 30 years since any new treatments have been developed. This is because researchers haven’t had
Scientists develop mini human heart organoid that mimics atrial fibrillation Read More »
Batya Swift Yasgur, MA, LSW December 09, 2025 As use of GLP-1 receptor agonists (RAs) continues to rise exponentially, awareness of its most common side effects, such as nausea and vomiting, is growing. But the drugs come with some lesser-known potential risks, which may include micronutrient deficiencies, such as iron deficiency anemia (IDA). “There may be a link between
Anemia: A Lesser-Known Side Effect of GLP-1 Drugs? Read More »
Vitae, vulputate lorem id egestas neque egestas habitant sit ante nec.
✆ Phone (appointments): 714-639-4013
Email: care@imedmg.com
Address: 615 E Chapman Ave, Suite #300, Orange, CA 92866